about
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5ADynamic imaging of the hepatitis C virus NS5A protein during a productive infection.Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin.The SR-BI partner PDZK1 facilitates hepatitis C virus entry.Viperin is an important host restriction factor in control of Zika virus infectionThe Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.Calsyntenin-1 mediates hepatitis C virus replication.HCV RNA traffic and association with NS5A in living cells.Phosphorylation of NS5A Serine-235 is essential to hepatitis C virus RNA replication and normal replication compartment formation.Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus.Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.FAT/CD36 expression alone is insufficient to enhance cellular uptake of oleate.A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation.Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake.Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment.Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.Genome-wide mutagenesis of dengue virus reveals plasticity of the NS1 protein and enables generation of infectious tagged reporter viruses.A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral action.Hepatitis C virus infection in living color.Closing the gap: the tight junction protein occludin and hepatitis C virus entry.Border patrol intensifies for hepatitis C virus entry.Current and future targets of antiviral therapy in the hepatitis C virus life cycleNS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice
P50
Q24632380-58EF496E-AEA9-4B4E-9AE0-0D3472BFA029Q30576516-D4612C22-408A-4E8C-B1B3-5B6D042B1558Q31116504-40A7AF57-D95A-44D2-8161-A86CD3A48986Q33719403-D66C78E4-1F8F-4AA6-8D5A-5548839E0E86Q33860964-88C4482C-94B1-444B-AAB6-C19C8ABEA4E4Q36283505-3D4C7D11-7F95-42C8-A934-0FFD764C879FQ38768742-447C65CE-4B2A-4B0B-BD97-7DE2482B154CQ38784494-1253D6C1-427B-47AD-BA1F-07A0B2D7A98CQ38794387-C8A7B1F4-866F-4F4A-A6AB-01B726835EE7Q38956477-C4189FF1-D3C1-46C7-9465-58B13E564ABDQ39148017-3163E0DB-7605-456E-B1DC-876AA3B20501Q39825918-4DC74D49-D00D-434B-836C-26D692596AF8Q39998857-C33C5545-9738-45C3-85A3-B8C5BD15EFF4Q40026040-9990807F-D6CD-492A-AD2E-6102C0907E5AQ40201530-B9922C45-A675-4A1A-BDD1-13DA31489E99Q40250013-DDF92BA2-26DF-42C0-8EE1-43D533344BB2Q41461350-9191D18A-0E82-4C0D-8ECF-29B3DC7B9973Q41928809-23C45265-2B70-4026-A1EB-760A8D37CBE4Q43035166-1A3D5328-B438-438D-97B4-F131AB5916AAQ43039082-EB528901-9891-4394-97AD-6DEA0AA0449CQ43417751-34BE741C-CEAC-4F6C-9EA2-29FBE7401DCDQ44468446-86E82875-B003-4604-A299-99AEBCAC4E56Q45362929-9BDAB82D-100C-4752-ACDA-2AF7C4BE2524Q57071775-A73B9D5D-0FC8-48C1-BB3E-F84A357DBFD6Q92028890-9BAE4A95-D4C0-47BA-A71E-089EE070B675
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicholas S Eyre
@ast
Nicholas S Eyre
@en
Nicholas S Eyre
@es
Nicholas S Eyre
@nl
Nicholas S Eyre
@sl
type
label
Nicholas S Eyre
@ast
Nicholas S Eyre
@en
Nicholas S Eyre
@es
Nicholas S Eyre
@nl
Nicholas S Eyre
@sl
prefLabel
Nicholas S Eyre
@ast
Nicholas S Eyre
@en
Nicholas S Eyre
@es
Nicholas S Eyre
@nl
Nicholas S Eyre
@sl
P106
P21
P31
P496
0000-0002-5424-7573